Mycobacterium Tuberculosis-IN-7
Mycobacterium Tuberculosis-IN-7 (Compound 4c) inhibits M. tuberculosis H37Ra with MIC of 5.34 μg/mL. Mycobacterium Tuberculosis-IN-7 exhibits slight cytotoxicity in cancer cell Vero, A549, and HepG2 (IC50s >50 μM) [1].
Product Specifications
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
COC1=C(NC2=NN(CCCC)C=C2)C(OC)=CC=C1
Molecular Formula
C15H21N3O2
Molecular Weight
275.35
References & Citations
[1]Wan G, et al., Discovery of 1,3-Disubstituted Pyrazole derivatives as Mycobacterium tuberculosis inhibitors. Bioorg Med Chem Lett. 2025 Feb 28;121:130156.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15234737 1 Vial
Lentiviral mouse Zfp248 shRNA (UAS) - Lentiviral mouse Zfp248 shRNA (UAS) (25)
Ask
View Details 
GTR15092561 1 Vial
Lentiviral human FOXC1 shRNA (UAS) - Lentiviral human FOXC1 shRNA (UAS) (25)
Ask
View Details 
MBS6147821-01 0.1 mL
ITGA1 (Integrin alpha-1, Integrin, alpha 1, CD49 Antigen-like Family Member A, CD49a, CD49a Antigen, Laminin and Collagen Receptor, Very Late Activation Protein 1, VLA1, VLA-1) (FITC)
Ask
View Details 
MBS6147821-02 5x 0.1 mL
ITGA1 (Integrin alpha-1, Integrin, alpha 1, CD49 Antigen-like Family Member A, CD49a, CD49a Antigen, Laminin and Collagen Receptor, Very Late Activation Protein 1, VLA1, VLA-1) (FITC)
Ask
View Details